nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—ABCC4—Verapamil—migraine	0.228	1	CbGbCtD
Alprostadil—PTGIR—blood vessel—migraine	0.00627	0.0915	CbGeAlD
Alprostadil—SLCO2A1—neck—migraine	0.00392	0.0572	CbGeAlD
Alprostadil—PTGIR—brainstem—migraine	0.00343	0.05	CbGeAlD
Alprostadil—SLCO3A1—trigeminal ganglion—migraine	0.00342	0.0499	CbGeAlD
Alprostadil—SLCO2A1—trigeminal ganglion—migraine	0.00339	0.0494	CbGeAlD
Alprostadil—ABCC5—trigeminal ganglion—migraine	0.0031	0.0452	CbGeAlD
Alprostadil—PTGER1—head—migraine	0.00307	0.0448	CbGeAlD
Alprostadil—PTGER1—nervous system—migraine	0.00291	0.0424	CbGeAlD
Alprostadil—PTGER1—central nervous system—migraine	0.0028	0.0409	CbGeAlD
Alprostadil—PTGIR—cardiovascular system—migraine	0.0028	0.0408	CbGeAlD
Alprostadil—PTGIR—head—migraine	0.00189	0.0277	CbGeAlD
Alprostadil—PTGIR—nervous system—migraine	0.0018	0.0262	CbGeAlD
Alprostadil—PTGIR—central nervous system—migraine	0.00173	0.0252	CbGeAlD
Alprostadil—PTGIR—cerebellum—migraine	0.00169	0.0247	CbGeAlD
Alprostadil—SLCO3A1—head—migraine	0.00167	0.0244	CbGeAlD
Alprostadil—SLCO2A1—head—migraine	0.00166	0.0242	CbGeAlD
Alprostadil—SLCO3A1—nervous system—migraine	0.00158	0.0231	CbGeAlD
Alprostadil—SLCO2A1—nervous system—migraine	0.00157	0.0229	CbGeAlD
Alprostadil—SLCO3A1—central nervous system—migraine	0.00153	0.0223	CbGeAlD
Alprostadil—SLCO2A1—central nervous system—migraine	0.00151	0.0221	CbGeAlD
Alprostadil—SLCO3A1—cerebellum—migraine	0.00149	0.0218	CbGeAlD
Alprostadil—PTGIR—brain—migraine	0.00137	0.02	CbGeAlD
Alprostadil—ABCC5—cerebellum—migraine	0.00135	0.0197	CbGeAlD
Alprostadil—PTGIR—GPCR ligand binding—RAMP1—migraine	0.00131	0.00512	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CALCRL—migraine	0.00131	0.00512	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—RAMP1—migraine	0.00131	0.00512	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CALCRL—migraine	0.00131	0.00512	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—HTR2B—migraine	0.00131	0.00512	CbGpPWpGaD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00131	0.00511	CbGpPWpGaD
Alprostadil—PTGIR—G alpha (s) signalling events—HTR7—migraine	0.00129	0.00506	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—TRPM8—migraine	0.00126	0.00493	CbGpPWpGaD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00126	0.00492	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00125	0.00489	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00125	0.00489	CbGpPWpGaD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00122	0.00475	CbGpPWpGaD
Alprostadil—SLCO3A1—brain—migraine	0.00121	0.0177	CbGeAlD
Alprostadil—ABCC5—Transmembrane transport of small molecules—TRPM8—migraine	0.00121	0.00471	CbGpPWpGaD
Alprostadil—SLCO2A1—brain—migraine	0.0012	0.0175	CbGeAlD
Alprostadil—SLCO2B1—head—migraine	0.00119	0.0173	CbGeAlD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00118	0.00463	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00116	0.00454	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00116	0.00454	CbGpPWpGaD
Alprostadil—SLCO2B1—nervous system—migraine	0.00112	0.0164	CbGeAlD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00112	0.00438	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—SLC6A4—migraine	0.00111	0.00436	CbGpPWpGaD
Alprostadil—ABCC5—brain—migraine	0.0011	0.016	CbGeAlD
Alprostadil—PTGER2—GPCR downstream signaling—CALCRL—migraine	0.0011	0.00428	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—RAMP1—migraine	0.0011	0.00428	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—TAC1—migraine	0.00108	0.00424	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—NPS—migraine	0.00108	0.00424	CbGpPWpGaD
Alprostadil—SLCO2B1—central nervous system—migraine	0.00108	0.0158	CbGeAlD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00108	0.00422	CbGpPWpGaD
Alprostadil—Shock—Amitriptyline—migraine	0.00108	0.00241	CcSEcCtD
Alprostadil—Thrombocytopenia—Amitriptyline—migraine	0.00107	0.0024	CcSEcCtD
Alprostadil—Flushing—Verapamil—migraine	0.00107	0.0024	CcSEcCtD
Alprostadil—Tachycardia—Amitriptyline—migraine	0.00107	0.00239	CcSEcCtD
Alprostadil—Injury—Gabapentin—migraine	0.00107	0.00239	CcSEcCtD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00107	0.00416	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—HTR2C—migraine	0.00106	0.00415	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00106	0.00415	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00106	0.00415	CbGpPWpGaD
Alprostadil—Hyperhidrosis—Amitriptyline—migraine	0.00106	0.00237	CcSEcCtD
Alprostadil—SLCO2B1—cerebellum—migraine	0.00106	0.0154	CbGeAlD
Alprostadil—Pain in extremity—Timolol—migraine	0.00105	0.00236	CcSEcCtD
Alprostadil—ABCC4—head—migraine	0.00105	0.0153	CbGeAlD
Alprostadil—Cramps of lower extremities—Topiramate—migraine	0.00104	0.00234	CcSEcCtD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00104	0.00407	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—EDNRA—migraine	0.00103	0.00404	CbGpPWpGaD
Alprostadil—Hypotension—Amitriptyline—migraine	0.00102	0.00229	CcSEcCtD
Alprostadil—Influenza—Valproic Acid—migraine	0.00102	0.00229	CcSEcCtD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.00101	0.00396	CbGpPWpGaD
Alprostadil—Hypoglycaemia—Gabapentin—migraine	0.00101	0.00225	CcSEcCtD
Alprostadil—Cardiac arrest—Timolol—migraine	0.001	0.00224	CcSEcCtD
Alprostadil—Lethargy—Gabapentin—migraine	0.001	0.00224	CcSEcCtD
Alprostadil—Sweating increased—Valproic Acid—migraine	0.000997	0.00223	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—RAMP1—migraine	0.000996	0.00389	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CALCRL—migraine	0.000996	0.00389	CbGpPWpGaD
Alprostadil—ABCC4—nervous system—migraine	0.000995	0.0145	CbGeAlD
Alprostadil—Abnormal vision—Topiramate—migraine	0.000992	0.00222	CcSEcCtD
Alprostadil—Bronchitis—Valproic Acid—migraine	0.000984	0.0022	CcSEcCtD
Alprostadil—Pain in extremity—Gabapentin—migraine	0.000981	0.00219	CcSEcCtD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00097	0.00379	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00097	0.00379	CbGpPWpGaD
Alprostadil—Muscle spasms—Verapamil—migraine	0.000967	0.00216	CcSEcCtD
Alprostadil—Dyspepsia—Amitriptyline—migraine	0.000964	0.00216	CcSEcCtD
Alprostadil—ABCC4—central nervous system—migraine	0.000958	0.014	CbGeAlD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000957	0.00374	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000957	0.00374	CbGpPWpGaD
Alprostadil—Cough—Propranolol—migraine	0.000954	0.00213	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—HTR1D—migraine	0.000952	0.00372	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—HTR1D—migraine	0.000952	0.00372	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000951	0.00372	CbGpPWpGaD
Alprostadil—Diabetes mellitus—Topiramate—migraine	0.000949	0.00212	CcSEcCtD
Alprostadil—Convulsion—Propranolol—migraine	0.000947	0.00212	CcSEcCtD
Alprostadil—Pollakiuria—Valproic Acid—migraine	0.000945	0.00211	CcSEcCtD
Alprostadil—Cardiac arrest—Gabapentin—migraine	0.000933	0.00209	CcSEcCtD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000925	0.00361	CbGpPWpGaD
Alprostadil—Blood creatinine increased—Gabapentin—migraine	0.000919	0.00206	CcSEcCtD
Alprostadil—ABCC5—Transmembrane transport of small molecules—ATP1A3—migraine	0.000914	0.00357	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—ATP1A2—migraine	0.000914	0.00357	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000913	0.00357	CbGpPWpGaD
Alprostadil—Nasal congestion—Topiramate—migraine	0.000906	0.00203	CcSEcCtD
Alprostadil—Feeling abnormal—Amitriptyline—migraine	0.000903	0.00202	CcSEcCtD
Alprostadil—Syncope—Verapamil—migraine	0.000902	0.00202	CcSEcCtD
Alprostadil—Urinary tract infection—Valproic Acid—migraine	0.000887	0.00198	CcSEcCtD
Alprostadil—Infection—Propranolol—migraine	0.000886	0.00198	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—HTR2B—migraine	0.000885	0.00346	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—HTR2B—migraine	0.000885	0.00346	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000884	0.00345	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000884	0.00345	CbGpPWpGaD
Alprostadil—Loss of consciousness—Verapamil—migraine	0.000884	0.00198	CcSEcCtD
Alprostadil—Convulsion—Verapamil—migraine	0.000871	0.00195	CcSEcCtD
Alprostadil—Hypertension—Verapamil—migraine	0.000868	0.00194	CcSEcCtD
Alprostadil—Skin disorder—Propranolol—migraine	0.000867	0.00194	CcSEcCtD
Alprostadil—Body temperature increased—Amitriptyline—migraine	0.000866	0.00194	CcSEcCtD
Alprostadil—SLCO2B1—brain—migraine	0.000859	0.0125	CbGeAlD
Alprostadil—Sinusitis—Valproic Acid—migraine	0.000856	0.00191	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—HTR1B—migraine	0.000854	0.00334	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000851	0.00333	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000851	0.00333	CbGpPWpGaD
Alprostadil—Influenza—Gabapentin—migraine	0.000848	0.0019	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Timolol—migraine	0.000847	0.00189	CcSEcCtD
Alprostadil—Hypoglycaemia—Topiramate—migraine	0.000846	0.00189	CcSEcCtD
Alprostadil—Discomfort—Verapamil—migraine	0.000846	0.00189	CcSEcCtD
Alprostadil—Lethargy—Topiramate—migraine	0.000843	0.00188	CcSEcCtD
Alprostadil—ABCC5—NRF2 pathway—TGFBR2—migraine	0.000841	0.00328	CbGpPWpGaD
Alprostadil—Dry mouth—Verapamil—migraine	0.000837	0.00187	CcSEcCtD
Alprostadil—ABCC4—Transmembrane transport of small molecules—TRPM8—migraine	0.000836	0.00327	CbGpPWpGaD
Alprostadil—Bradycardia—Valproic Acid—migraine	0.000834	0.00186	CcSEcCtD
Alprostadil—Sweating increased—Gabapentin—migraine	0.000826	0.00185	CcSEcCtD
Alprostadil—Pain in extremity—Topiramate—migraine	0.000826	0.00185	CcSEcCtD
Alprostadil—Haemoglobin—Valproic Acid—migraine	0.000823	0.00184	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—HTR1A—migraine	0.000822	0.00321	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000822	0.00321	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000822	0.00321	CbGpPWpGaD
Alprostadil—Hyperglycaemia—Timolol—migraine	0.000822	0.00184	CcSEcCtD
Alprostadil—Rhinitis—Valproic Acid—migraine	0.000821	0.00184	CcSEcCtD
Alprostadil—Oedema—Verapamil—migraine	0.000821	0.00184	CcSEcCtD
Alprostadil—Haemorrhage—Valproic Acid—migraine	0.000819	0.00183	CcSEcCtD
Alprostadil—Bronchitis—Gabapentin—migraine	0.000816	0.00182	CcSEcCtD
Alprostadil—Infection—Verapamil—migraine	0.000815	0.00182	CcSEcCtD
Alprostadil—Hypoaesthesia—Valproic Acid—migraine	0.000815	0.00182	CcSEcCtD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—HTR3A—migraine	0.000814	0.00318	CbGpPWpGaD
Alprostadil—Pharyngitis—Valproic Acid—migraine	0.000813	0.00182	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—TAC1—migraine	0.00081	0.00316	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—NPS—migraine	0.00081	0.00316	CbGpPWpGaD
Alprostadil—Shock—Verapamil—migraine	0.000807	0.00181	CcSEcCtD
Alprostadil—Urethral disorder—Valproic Acid—migraine	0.000803	0.0018	CcSEcCtD
Alprostadil—Tachycardia—Verapamil—migraine	0.000801	0.00179	CcSEcCtD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.0008	0.00312	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.0008	0.00312	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—HTR1D—migraine	0.000797	0.00311	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—HTR2C—migraine	0.000794	0.0031	CbGpPWpGaD
Alprostadil—Hyperhidrosis—Verapamil—migraine	0.000793	0.00177	CcSEcCtD
Alprostadil—Visual impairment—Valproic Acid—migraine	0.000789	0.00177	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Gabapentin—migraine	0.000788	0.00176	CcSEcCtD
Alprostadil—Asthenia—Amitriptyline—migraine	0.000786	0.00176	CcSEcCtD
Alprostadil—Dyspepsia—Propranolol—migraine	0.000785	0.00176	CcSEcCtD
Alprostadil—Pollakiuria—Gabapentin—migraine	0.000784	0.00175	CcSEcCtD
Alprostadil—ABCC5—Transmembrane transport of small molecules—HTR3A—migraine	0.000777	0.00304	CbGpPWpGaD
Alprostadil—Pruritus—Amitriptyline—migraine	0.000775	0.00173	CcSEcCtD
Alprostadil—Blood creatinine increased—Topiramate—migraine	0.000774	0.00173	CcSEcCtD
Alprostadil—ABCC4—NRF2 pathway—SLC6A4—migraine	0.000773	0.00302	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—EDNRA—migraine	0.000772	0.00302	CbGpPWpGaD
Alprostadil—Hypotension—Verapamil—migraine	0.000767	0.00171	CcSEcCtD
Alprostadil—Hyperglycaemia—Gabapentin—migraine	0.000765	0.00171	CcSEcCtD
Alprostadil—Pain—Propranolol—migraine	0.000763	0.00171	CcSEcCtD
Alprostadil—Sinusitis—Timolol—migraine	0.000762	0.0017	CcSEcCtD
Alprostadil—ABCC4—brain—migraine	0.000761	0.0111	CbGeAlD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000758	0.00296	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000758	0.00296	CbGpPWpGaD
Alprostadil—Hypokalaemia—Topiramate—migraine	0.000751	0.00168	CcSEcCtD
Alprostadil—Diarrhoea—Amitriptyline—migraine	0.00075	0.00168	CcSEcCtD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000747	0.00292	CbGpPWpGaD
Alprostadil—Acute coronary syndrome—Gabapentin—migraine	0.000746	0.00167	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—CALCA—migraine	0.000743	0.0029	CbGpPWpGaD
Alprostadil—Renal failure—Gabapentin—migraine	0.000743	0.00166	CcSEcCtD
Alprostadil—Bradycardia—Timolol—migraine	0.000742	0.00166	CcSEcCtD
Alprostadil—Myocardial infarction—Gabapentin—migraine	0.000741	0.00166	CcSEcCtD
Alprostadil—PTGER1—GPCR downstream signaling—RAMP1—migraine	0.000741	0.00289	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CALCRL—migraine	0.000741	0.00289	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—RAMP1—migraine	0.000741	0.00289	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CALCRL—migraine	0.000741	0.00289	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—HTR2B—migraine	0.000741	0.00289	CbGpPWpGaD
Alprostadil—Urinary tract infection—Gabapentin—migraine	0.000735	0.00164	CcSEcCtD
Alprostadil—Rhinitis—Timolol—migraine	0.000731	0.00163	CcSEcCtD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000729	0.00285	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000729	0.00285	CbGpPWpGaD
Alprostadil—Dizziness—Amitriptyline—migraine	0.000725	0.00162	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—HTR1D—migraine	0.000723	0.00283	CbGpPWpGaD
Alprostadil—Dyspepsia—Verapamil—migraine	0.000722	0.00162	CcSEcCtD
Alprostadil—Haematuria—Gabapentin—migraine	0.000721	0.00161	CcSEcCtD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00072	0.00281	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00072	0.00281	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000718	0.00281	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000718	0.00281	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000718	0.00281	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000718	0.00281	CbGpPWpGaD
Alprostadil—Sinusitis—Gabapentin—migraine	0.00071	0.00159	CcSEcCtD
Alprostadil—Body temperature increased—Propranolol—migraine	0.000705	0.00158	CcSEcCtD
Alprostadil—Abdominal pain—Propranolol—migraine	0.000705	0.00158	CcSEcCtD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000704	0.00275	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000704	0.00275	CbGpPWpGaD
Alprostadil—Visual impairment—Timolol—migraine	0.000703	0.00157	CcSEcCtD
Alprostadil—Pain—Verapamil—migraine	0.000702	0.00157	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—HTR7—migraine	0.000695	0.00272	CbGpPWpGaD
Alprostadil—Sweating increased—Topiramate—migraine	0.000695	0.00155	CcSEcCtD
Alprostadil—Nervousness—Valproic Acid—migraine	0.000692	0.00155	CcSEcCtD
Alprostadil—Bradycardia—Gabapentin—migraine	0.000691	0.00155	CcSEcCtD
Alprostadil—Rash—Amitriptyline—migraine	0.000691	0.00154	CcSEcCtD
Alprostadil—Dermatitis—Amitriptyline—migraine	0.00069	0.00154	CcSEcCtD
Alprostadil—Back pain—Valproic Acid—migraine	0.00069	0.00154	CcSEcCtD
Alprostadil—Headache—Amitriptyline—migraine	0.000686	0.00154	CcSEcCtD
Alprostadil—Bronchitis—Topiramate—migraine	0.000686	0.00153	CcSEcCtD
Alprostadil—Muscle spasms—Valproic Acid—migraine	0.000685	0.00153	CcSEcCtD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000685	0.00268	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000685	0.00268	CbGpPWpGaD
Alprostadil—Rhinitis—Gabapentin—migraine	0.000681	0.00152	CcSEcCtD
Alprostadil—Haemorrhage—Gabapentin—migraine	0.000679	0.00152	CcSEcCtD
Alprostadil—Feeling abnormal—Verapamil—migraine	0.000676	0.00151	CcSEcCtD
Alprostadil—Hypoaesthesia—Gabapentin—migraine	0.000676	0.00151	CcSEcCtD
Alprostadil—Pharyngitis—Gabapentin—migraine	0.000674	0.00151	CcSEcCtD
Alprostadil—PTGER1—Signaling by GPCR—RAMP1—migraine	0.000673	0.00263	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—RAMP1—migraine	0.000673	0.00263	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CALCRL—migraine	0.000673	0.00263	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CALCRL—migraine	0.000673	0.00263	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—HTR2B—migraine	0.000673	0.00263	CbGpPWpGaD
Alprostadil—Urethral disorder—Gabapentin—migraine	0.000666	0.00149	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Topiramate—migraine	0.000663	0.00148	CcSEcCtD
Alprostadil—Pollakiuria—Topiramate—migraine	0.000659	0.00147	CcSEcCtD
Alprostadil—Anaemia—Valproic Acid—migraine	0.000659	0.00147	CcSEcCtD
Alprostadil—Visual impairment—Gabapentin—migraine	0.000654	0.00146	CcSEcCtD
Alprostadil—PTGER1—G alpha (q) signalling events—HTR2A—migraine	0.000652	0.00255	CbGpPWpGaD
Alprostadil—Nausea—Amitriptyline—migraine	0.000651	0.00146	CcSEcCtD
Alprostadil—Hyperglycaemia—Topiramate—migraine	0.000644	0.00144	CcSEcCtD
Alprostadil—Asthenia—Propranolol—migraine	0.00064	0.00143	CcSEcCtD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.00064	0.0025	CbGpPWpGaD
Alprostadil—Erythema—Timolol—migraine	0.000635	0.00142	CcSEcCtD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ATP1A3—migraine	0.000634	0.00248	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ATP1A2—migraine	0.000634	0.00248	CbGpPWpGaD
Alprostadil—Renal failure—Topiramate—migraine	0.000625	0.0014	CcSEcCtD
Alprostadil—Cough—Valproic Acid—migraine	0.000622	0.00139	CcSEcCtD
Alprostadil—Urinary tract infection—Topiramate—migraine	0.000618	0.00138	CcSEcCtD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000617	0.00241	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000617	0.00241	CbGpPWpGaD
Alprostadil—Nervousness—Timolol—migraine	0.000616	0.00138	CcSEcCtD
Alprostadil—Hypertension—Valproic Acid—migraine	0.000616	0.00138	CcSEcCtD
Alprostadil—Diarrhoea—Propranolol—migraine	0.00061	0.00137	CcSEcCtD
Alprostadil—Haematuria—Topiramate—migraine	0.000607	0.00136	CcSEcCtD
Alprostadil—Discomfort—Valproic Acid—migraine	0.0006	0.00134	CcSEcCtD
Alprostadil—Sinusitis—Topiramate—migraine	0.000597	0.00134	CcSEcCtD
Alprostadil—Dry mouth—Valproic Acid—migraine	0.000594	0.00133	CcSEcCtD
Alprostadil—Erythema—Gabapentin—migraine	0.000591	0.00132	CcSEcCtD
Alprostadil—Dizziness—Propranolol—migraine	0.00059	0.00132	CcSEcCtD
Alprostadil—Asthenia—Verapamil—migraine	0.000589	0.00132	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—RAMP1—migraine	0.000588	0.0023	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CALCRL—migraine	0.000588	0.0023	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000583	0.00228	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—TGFBR2—migraine	0.000583	0.00228	CbGpPWpGaD
Alprostadil—Oedema—Valproic Acid—migraine	0.000582	0.0013	CcSEcCtD
Alprostadil—Bradycardia—Topiramate—migraine	0.000581	0.0013	CcSEcCtD
Alprostadil—Pruritus—Verapamil—migraine	0.000581	0.0013	CcSEcCtD
Alprostadil—Infection—Valproic Acid—migraine	0.000578	0.00129	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—HTR1B—migraine	0.000577	0.00225	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—HTR1B—migraine	0.000577	0.00225	CbGpPWpGaD
Alprostadil—Haemoglobin—Topiramate—migraine	0.000574	0.00128	CcSEcCtD
Alprostadil—Nervousness—Gabapentin—migraine	0.000574	0.00128	CcSEcCtD
Alprostadil—Rhinitis—Topiramate—migraine	0.000573	0.00128	CcSEcCtD
Alprostadil—Back pain—Gabapentin—migraine	0.000572	0.00128	CcSEcCtD
Alprostadil—Haemorrhage—Topiramate—migraine	0.000571	0.00128	CcSEcCtD
Alprostadil—Thrombocytopenia—Valproic Acid—migraine	0.00057	0.00127	CcSEcCtD
Alprostadil—Syncope—Timolol—migraine	0.000569	0.00127	CcSEcCtD
Alprostadil—Hypoaesthesia—Topiramate—migraine	0.000568	0.00127	CcSEcCtD
Alprostadil—Muscle spasms—Gabapentin—migraine	0.000568	0.00127	CcSEcCtD
Alprostadil—Tachycardia—Valproic Acid—migraine	0.000568	0.00127	CcSEcCtD
Alprostadil—Pharyngitis—Topiramate—migraine	0.000567	0.00127	CcSEcCtD
Alprostadil—Skin disorder—Valproic Acid—migraine	0.000565	0.00126	CcSEcCtD
Alprostadil—Hyperhidrosis—Valproic Acid—migraine	0.000562	0.00126	CcSEcCtD
Alprostadil—Rash—Propranolol—migraine	0.000562	0.00126	CcSEcCtD
Alprostadil—Dermatitis—Propranolol—migraine	0.000562	0.00126	CcSEcCtD
Alprostadil—Diarrhoea—Verapamil—migraine	0.000561	0.00126	CcSEcCtD
Alprostadil—Urethral disorder—Topiramate—migraine	0.00056	0.00125	CcSEcCtD
Alprostadil—Loss of consciousness—Timolol—migraine	0.000558	0.00125	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—HTR1A—migraine	0.000555	0.00217	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—HTR1A—migraine	0.000555	0.00217	CbGpPWpGaD
Alprostadil—Cough—Timolol—migraine	0.000554	0.00124	CcSEcCtD
Alprostadil—Visual impairment—Topiramate—migraine	0.00055	0.00123	CcSEcCtD
Alprostadil—Hypertension—Timolol—migraine	0.000548	0.00123	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—NPS—migraine	0.000547	0.00214	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—TAC1—migraine	0.000547	0.00214	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—TAC1—migraine	0.000547	0.00214	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—NPS—migraine	0.000547	0.00214	CbGpPWpGaD
Alprostadil—Anaemia—Gabapentin—migraine	0.000546	0.00122	CcSEcCtD
Alprostadil—Hypotension—Valproic Acid—migraine	0.000544	0.00122	CcSEcCtD
Alprostadil—Dizziness—Verapamil—migraine	0.000543	0.00121	CcSEcCtD
Alprostadil—ABCC4—Transmembrane transport of small molecules—HTR3A—migraine	0.000539	0.00211	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—HTR1D—migraine	0.000538	0.0021	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—HTR1D—migraine	0.000538	0.0021	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—HTR2C—migraine	0.000536	0.0021	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—HTR2C—migraine	0.000536	0.0021	CbGpPWpGaD
Alprostadil—Discomfort—Timolol—migraine	0.000534	0.00119	CcSEcCtD
Alprostadil—Flushing—Topiramate—migraine	0.00053	0.00119	CcSEcCtD
Alprostadil—Syncope—Gabapentin—migraine	0.00053	0.00119	CcSEcCtD
Alprostadil—Nausea—Propranolol—migraine	0.00053	0.00119	CcSEcCtD
Alprostadil—Dry mouth—Timolol—migraine	0.000528	0.00118	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—EDNRA—migraine	0.000522	0.00204	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—EDNRA—migraine	0.000522	0.00204	CbGpPWpGaD
Alprostadil—Loss of consciousness—Gabapentin—migraine	0.000519	0.00116	CcSEcCtD
Alprostadil—Oedema—Timolol—migraine	0.000518	0.00116	CcSEcCtD
Alprostadil—Rash—Verapamil—migraine	0.000517	0.00116	CcSEcCtD
Alprostadil—Dermatitis—Verapamil—migraine	0.000517	0.00116	CcSEcCtD
Alprostadil—Cough—Gabapentin—migraine	0.000516	0.00115	CcSEcCtD
Alprostadil—Infection—Timolol—migraine	0.000515	0.00115	CcSEcCtD
Alprostadil—Headache—Verapamil—migraine	0.000514	0.00115	CcSEcCtD
Alprostadil—Dyspepsia—Valproic Acid—migraine	0.000512	0.00115	CcSEcCtD
Alprostadil—Convulsion—Gabapentin—migraine	0.000512	0.00115	CcSEcCtD
Alprostadil—Hypertension—Gabapentin—migraine	0.00051	0.00114	CcSEcCtD
Alprostadil—Shock—Timolol—migraine	0.00051	0.00114	CcSEcCtD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000504	0.00197	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000504	0.00197	CbGpPWpGaD
Alprostadil—Skin disorder—Timolol—migraine	0.000503	0.00113	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—CALCA—migraine	0.000502	0.00196	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CALCA—migraine	0.000502	0.00196	CbGpPWpGaD
Alprostadil—Hyperhidrosis—Timolol—migraine	0.000501	0.00112	CcSEcCtD
Alprostadil—PTGER1—GPCR downstream signaling—HTR2B—migraine	0.0005	0.00195	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—HTR2B—migraine	0.0005	0.00195	CbGpPWpGaD
Alprostadil—Pain—Valproic Acid—migraine	0.000498	0.00111	CcSEcCtD
Alprostadil—Erythema—Topiramate—migraine	0.000497	0.00111	CcSEcCtD
Alprostadil—Discomfort—Gabapentin—migraine	0.000497	0.00111	CcSEcCtD
Alprostadil—Dry mouth—Gabapentin—migraine	0.000492	0.0011	CcSEcCtD
Alprostadil—PTGER1—Signaling by GPCR—HTR1D—migraine	0.000489	0.00191	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HTR1D—migraine	0.000489	0.00191	CbGpPWpGaD
Alprostadil—Nausea—Verapamil—migraine	0.000487	0.00109	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—HTR2A—migraine	0.000487	0.0019	CbGpPWpGaD
Alprostadil—Hypotension—Timolol—migraine	0.000484	0.00108	CcSEcCtD
Alprostadil—Nervousness—Topiramate—migraine	0.000483	0.00108	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—HTR1B—migraine	0.000483	0.00189	CbGpPWpGaD
Alprostadil—Oedema—Gabapentin—migraine	0.000482	0.00108	CcSEcCtD
Alprostadil—Back pain—Topiramate—migraine	0.000481	0.00108	CcSEcCtD
Alprostadil—Feeling abnormal—Valproic Acid—migraine	0.000479	0.00107	CcSEcCtD
Alprostadil—Infection—Gabapentin—migraine	0.000479	0.00107	CcSEcCtD
Alprostadil—Muscle spasms—Topiramate—migraine	0.000478	0.00107	CcSEcCtD
Alprostadil—Shock—Gabapentin—migraine	0.000475	0.00106	CcSEcCtD
Alprostadil—Thrombocytopenia—Gabapentin—migraine	0.000472	0.00106	CcSEcCtD
Alprostadil—Tachycardia—Gabapentin—migraine	0.000471	0.00105	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—HTR7—migraine	0.00047	0.00184	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—HTR7—migraine	0.00047	0.00184	CbGpPWpGaD
Alprostadil—Skin disorder—Gabapentin—migraine	0.000469	0.00105	CcSEcCtD
Alprostadil—Hyperhidrosis—Gabapentin—migraine	0.000466	0.00104	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—HTR1A—migraine	0.000465	0.00182	CbGpPWpGaD
Alprostadil—Body temperature increased—Valproic Acid—migraine	0.00046	0.00103	CcSEcCtD
Alprostadil—Abdominal pain—Valproic Acid—migraine	0.00046	0.00103	CcSEcCtD
Alprostadil—Anaemia—Topiramate—migraine	0.00046	0.00103	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—NPS—migraine	0.000458	0.00179	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—TAC1—migraine	0.000458	0.00179	CbGpPWpGaD
Alprostadil—Dyspepsia—Timolol—migraine	0.000456	0.00102	CcSEcCtD
Alprostadil—PTGER1—Signaling by GPCR—HTR2B—migraine	0.000454	0.00177	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HTR2B—migraine	0.000454	0.00177	CbGpPWpGaD
Alprostadil—Hypotension—Gabapentin—migraine	0.000451	0.00101	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—HTR2C—migraine	0.000449	0.00175	CbGpPWpGaD
Alprostadil—Syncope—Topiramate—migraine	0.000446	0.000997	CcSEcCtD
Alprostadil—Pain—Timolol—migraine	0.000443	0.000991	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—HTR1B—migraine	0.000438	0.00171	CbGpPWpGaD
Alprostadil—Loss of consciousness—Topiramate—migraine	0.000437	0.000977	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—EDNRA—migraine	0.000436	0.00171	CbGpPWpGaD
Alprostadil—Cough—Topiramate—migraine	0.000434	0.00097	CcSEcCtD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000432	0.00169	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000432	0.00169	CbGpPWpGaD
Alprostadil—Convulsion—Topiramate—migraine	0.000431	0.000963	CcSEcCtD
Alprostadil—Hypertension—Topiramate—migraine	0.000429	0.00096	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—HTR1D—migraine	0.000427	0.00167	CbGpPWpGaD
Alprostadil—Feeling abnormal—Timolol—migraine	0.000427	0.000955	CcSEcCtD
Alprostadil—Dyspepsia—Gabapentin—migraine	0.000425	0.00095	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—HTR1A—migraine	0.000422	0.00165	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—CALCA—migraine	0.00042	0.00164	CbGpPWpGaD
Alprostadil—Discomfort—Topiramate—migraine	0.000418	0.000935	CcSEcCtD
Alprostadil—Asthenia—Valproic Acid—migraine	0.000417	0.000934	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—NPS—migraine	0.000415	0.00162	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—TAC1—migraine	0.000415	0.00162	CbGpPWpGaD
Alprostadil—Dry mouth—Topiramate—migraine	0.000414	0.000926	CcSEcCtD
Alprostadil—Pain—Gabapentin—migraine	0.000412	0.000922	CcSEcCtD
Alprostadil—Pruritus—Valproic Acid—migraine	0.000412	0.000921	CcSEcCtD
Alprostadil—Abdominal pain—Timolol—migraine	0.000409	0.000916	CcSEcCtD
Alprostadil—Body temperature increased—Timolol—migraine	0.000409	0.000916	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—HTR2C—migraine	0.000407	0.00159	CbGpPWpGaD
Alprostadil—Oedema—Topiramate—migraine	0.000406	0.000908	CcSEcCtD
Alprostadil—Infection—Topiramate—migraine	0.000403	0.000902	CcSEcCtD
Alprostadil—Shock—Topiramate—migraine	0.000399	0.000893	CcSEcCtD
Alprostadil—Diarrhoea—Valproic Acid—migraine	0.000398	0.00089	CcSEcCtD
Alprostadil—Feeling abnormal—Gabapentin—migraine	0.000397	0.000889	CcSEcCtD
Alprostadil—Thrombocytopenia—Topiramate—migraine	0.000397	0.000889	CcSEcCtD
Alprostadil—PTGIR—Signaling Pathways—RAMP1—migraine	0.000397	0.00155	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CALCRL—migraine	0.000397	0.00155	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RAMP1—migraine	0.000397	0.00155	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CALCRL—migraine	0.000397	0.00155	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HTR2B—migraine	0.000397	0.00155	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—EDNRA—migraine	0.000396	0.00155	CbGpPWpGaD
Alprostadil—Tachycardia—Topiramate—migraine	0.000396	0.000886	CcSEcCtD
Alprostadil—Skin disorder—Topiramate—migraine	0.000394	0.000882	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—HTR7—migraine	0.000393	0.00154	CbGpPWpGaD
Alprostadil—Hyperhidrosis—Topiramate—migraine	0.000392	0.000877	CcSEcCtD
Alprostadil—Dizziness—Valproic Acid—migraine	0.000385	0.00086	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—CALCA—migraine	0.000382	0.00149	CbGpPWpGaD
Alprostadil—Body temperature increased—Gabapentin—migraine	0.000381	0.000853	CcSEcCtD
Alprostadil—Abdominal pain—Gabapentin—migraine	0.000381	0.000853	CcSEcCtD
Alprostadil—Hypotension—Topiramate—migraine	0.000379	0.000848	CcSEcCtD
Alprostadil—Asthenia—Timolol—migraine	0.000372	0.000831	CcSEcCtD
Alprostadil—Rash—Valproic Acid—migraine	0.000367	0.00082	CcSEcCtD
Alprostadil—Dermatitis—Valproic Acid—migraine	0.000367	0.00082	CcSEcCtD
Alprostadil—Pruritus—Timolol—migraine	0.000366	0.00082	CcSEcCtD
Alprostadil—Headache—Valproic Acid—migraine	0.000365	0.000815	CcSEcCtD
Alprostadil—Dyspepsia—Topiramate—migraine	0.000357	0.000799	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—HTR7—migraine	0.000357	0.00139	CbGpPWpGaD
Alprostadil—Diarrhoea—Timolol—migraine	0.000354	0.000793	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—LRP1—migraine	0.00035	0.00137	CbGpPWpGaD
Alprostadil—Pain—Topiramate—migraine	0.000347	0.000776	CcSEcCtD
Alprostadil—Asthenia—Gabapentin—migraine	0.000346	0.000774	CcSEcCtD
Alprostadil—Nausea—Valproic Acid—migraine	0.000346	0.000773	CcSEcCtD
Alprostadil—Dizziness—Timolol—migraine	0.000343	0.000766	CcSEcCtD
Alprostadil—Pruritus—Gabapentin—migraine	0.000341	0.000763	CcSEcCtD
Alprostadil—Feeling abnormal—Topiramate—migraine	0.000334	0.000748	CcSEcCtD
Alprostadil—Diarrhoea—Gabapentin—migraine	0.00033	0.000738	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—HTR2A—migraine	0.000329	0.00129	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—HTR2A—migraine	0.000329	0.00129	CbGpPWpGaD
Alprostadil—Rash—Timolol—migraine	0.000327	0.00073	CcSEcCtD
Alprostadil—Dermatitis—Timolol—migraine	0.000326	0.00073	CcSEcCtD
Alprostadil—PTGER1—GPCR downstream signaling—HTR1B—migraine	0.000326	0.00127	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—HTR1B—migraine	0.000326	0.00127	CbGpPWpGaD
Alprostadil—Headache—Timolol—migraine	0.000324	0.000726	CcSEcCtD
Alprostadil—Body temperature increased—Topiramate—migraine	0.000321	0.000717	CcSEcCtD
Alprostadil—Abdominal pain—Topiramate—migraine	0.000321	0.000717	CcSEcCtD
Alprostadil—Dizziness—Gabapentin—migraine	0.000319	0.000713	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—HTR1A—migraine	0.000314	0.00123	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—HTR1A—migraine	0.000314	0.00123	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CACNA1A—migraine	0.00031	0.00121	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—TAC1—migraine	0.000309	0.00121	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—TAC1—migraine	0.000309	0.00121	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—NPS—migraine	0.000309	0.00121	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—NPS—migraine	0.000309	0.00121	CbGpPWpGaD
Alprostadil—Nausea—Timolol—migraine	0.000308	0.000688	CcSEcCtD
Alprostadil—Rash—Gabapentin—migraine	0.000304	0.00068	CcSEcCtD
Alprostadil—Dermatitis—Gabapentin—migraine	0.000304	0.00068	CcSEcCtD
Alprostadil—PTGER1—GPCR downstream signaling—HTR2C—migraine	0.000303	0.00118	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—HTR2C—migraine	0.000303	0.00118	CbGpPWpGaD
Alprostadil—Headache—Gabapentin—migraine	0.000302	0.000676	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—HTR1B—migraine	0.000296	0.00116	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—HTR1B—migraine	0.000296	0.00116	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—EDNRA—migraine	0.000295	0.00115	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—EDNRA—migraine	0.000295	0.00115	CbGpPWpGaD
Alprostadil—Asthenia—Topiramate—migraine	0.000291	0.000651	CcSEcCtD
Alprostadil—ABCC5—Disease—LRP1—migraine	0.00029	0.00113	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR1D—migraine	0.000289	0.00113	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR1D—migraine	0.000289	0.00113	CbGpPWpGaD
Alprostadil—Pruritus—Topiramate—migraine	0.000287	0.000642	CcSEcCtD
Alprostadil—Nausea—Gabapentin—migraine	0.000287	0.000641	CcSEcCtD
Alprostadil—PTGER1—Signaling by GPCR—HTR1A—migraine	0.000285	0.00111	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HTR1A—migraine	0.000285	0.00111	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CALCA—migraine	0.000284	0.00111	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CALCA—migraine	0.000284	0.00111	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—TAC1—migraine	0.000281	0.0011	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—TAC1—migraine	0.000281	0.0011	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—NPS—migraine	0.000281	0.0011	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—NPS—migraine	0.000281	0.0011	CbGpPWpGaD
Alprostadil—Diarrhoea—Topiramate—migraine	0.000278	0.000621	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—HTR2A—migraine	0.000275	0.00108	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HTR2C—migraine	0.000275	0.00108	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—HTR2C—migraine	0.000275	0.00108	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOTCH4—migraine	0.000268	0.00105	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR2B—migraine	0.000268	0.00105	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR2B—migraine	0.000268	0.00105	CbGpPWpGaD
Alprostadil—Dizziness—Topiramate—migraine	0.000268	0.0006	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—EDNRA—migraine	0.000268	0.00105	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—EDNRA—migraine	0.000268	0.00105	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—HTR7—migraine	0.000265	0.00104	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—HTR7—migraine	0.000265	0.00104	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HTR1B—migraine	0.000259	0.00101	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CALCA—migraine	0.000258	0.00101	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CALCA—migraine	0.000258	0.00101	CbGpPWpGaD
Alprostadil—Rash—Topiramate—migraine	0.000256	0.000572	CcSEcCtD
Alprostadil—Dermatitis—Topiramate—migraine	0.000256	0.000572	CcSEcCtD
Alprostadil—Headache—Topiramate—migraine	0.000254	0.000569	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—HTR2A—migraine	0.00025	0.000977	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HTR1A—migraine	0.000249	0.000974	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TAC1—migraine	0.000245	0.000959	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PGR—migraine	0.000245	0.000959	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NPS—migraine	0.000245	0.000959	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—HTR7—migraine	0.000241	0.000942	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HTR7—migraine	0.000241	0.000942	CbGpPWpGaD
Alprostadil—Nausea—Topiramate—migraine	0.000241	0.000539	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—HTR2C—migraine	0.000241	0.00094	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LRP1—migraine	0.000236	0.000923	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LRP1—migraine	0.000236	0.000923	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EDNRA—migraine	0.000234	0.000915	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOTCH3—migraine	0.000228	0.000891	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CALCA—migraine	0.000225	0.000881	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HTR7—migraine	0.000211	0.000824	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CALCA—migraine	0.000187	0.00073	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—HTR2A—migraine	0.000186	0.000726	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—HTR2A—migraine	0.000186	0.000726	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TGFBR2—migraine	0.000182	0.000709	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOTCH4—migraine	0.000181	0.000708	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOTCH4—migraine	0.000181	0.000708	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR1B—migraine	0.000175	0.000683	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR1B—migraine	0.000175	0.000683	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—HTR2A—migraine	0.000169	0.00066	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HTR2A—migraine	0.000169	0.00066	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR1A—migraine	0.000168	0.000658	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR1A—migraine	0.000168	0.000658	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PGR—migraine	0.000166	0.000648	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NPS—migraine	0.000166	0.000648	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PGR—migraine	0.000166	0.000648	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TAC1—migraine	0.000166	0.000648	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TAC1—migraine	0.000166	0.000648	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NPS—migraine	0.000166	0.000648	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR2C—migraine	0.000163	0.000635	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR2C—migraine	0.000163	0.000635	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EDNRA—migraine	0.000158	0.000618	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EDNRA—migraine	0.000158	0.000618	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOTCH3—migraine	0.000154	0.000602	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOTCH3—migraine	0.000154	0.000602	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CALCA—migraine	0.000152	0.000595	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CALCA—migraine	0.000152	0.000595	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TGFBR2—migraine	0.000151	0.000588	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HTR2A—migraine	0.000148	0.000577	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR7—migraine	0.000142	0.000556	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR7—migraine	0.000142	0.000556	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ESR1—migraine	0.000131	0.000512	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TGFBR2—migraine	0.000123	0.000479	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TGFBR2—migraine	0.000123	0.000479	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTHFR—migraine	0.000122	0.000478	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MTHFR—migraine	0.000102	0.0004	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR2A—migraine	9.97e-05	0.00039	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR2A—migraine	9.97e-05	0.00039	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ESR1—migraine	8.85e-05	0.000346	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ESR1—migraine	8.85e-05	0.000346	CbGpPWpGaD
